Skip to main content
main-content

01.12.2018 | Correction | Ausgabe 1/2018 Open Access

The Journal of Headache and Pain 1/2018

Correction to: Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial

Zeitschrift:
The Journal of Headache and Pain > Ausgabe 1/2018
Autoren:
Paolo Martelletti, Piero Barbanti, Licia Grazzi, Giulia Pierangeli, Innocenzo Rainero, Pierangelo Geppetti, Anna Ambrosini, Paola Sarchielli, Cristina Tassorelli, Eric Liebler, Marina de Tommaso, on Behalf of the PRESTO Study Group
Wichtige Hinweise
The original article can be found online at https://​doi.​org/​10.​1186/​s10194-018-0929-0

Correction

Following publication of the original article [ 1], the authors notified us that the citation within the Table 1 legend was not presented as initially requested. Also, the word “efficacy” was missed from the background section.
The original publication has been corrected. The incorrect and correct table citations as well as background information are presented below.
  • Originally published citation:
© 2018 Tassorelli C, Grazzi L, de Tommaso M, Pierangeli G, Martelletti P, Rainero I, Dorlas S, Geppetti P, Ambrosini A, Sarchielli P, Liebler E, Barbanti P, PRESTO Study Group (2018) Non-invasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study [published online June 15, 2018]. Neurology: https://​doi.​org/​10.​1212/​WNL.​0000000000005857​. www.​neurology.​org. Adapted with permission
Abbreviations: DB Double-blind, NA Not applicable, nVNS Non-invasive vagus nerve stimulation, SD Standard deviation
aNo. of days the patient typically takes acute migraine medication per month. bPatients with no reported baseline severity were excluded from this analysis
  • Corrected citation:
© 2018 Tassorelli C, Grazzi L, de Tommaso M, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364-e373. Adapted with permission
  • Original Background paragraph:
Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented but remain frequently used in the emergency department setting, which significantly increases healthcare costs
  • Corrected Background paragraph:
Opioids should be discouraged for the acute treatment of migraine due to significant safety concerns and lack of documented efficacy but remain frequently used in the emergency department setting, which significantly increases healthcare costs
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2018

The Journal of Headache and Pain 1/2018 Zur Ausgabe

Neu im Fachgebiet AINS

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update AINS und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise